CAR-T 细胞治疗:儿童中线胶质瘤的潜在治疗策略
CAR T-cell therapy: a potential treatment strategy for pediatric midline gliomas.
弥漫性中线胶质瘤(DMG)和弥漫性内生性桥脑胶质瘤(DIPG)因位置难以到达而常常无法手术切除,5 年生存率仍低于 20%。
32.4分
★☆☆☆☆
ALL SOURCES
CAR T-cell therapy: a potential treatment strategy for pediatric midline gliomas.
弥漫性中线胶质瘤(DMG)和弥漫性内生性桥脑胶质瘤(DIPG)因位置难以到达而常常无法手术切除,5 年生存率仍低于 20%。
Current and future perspectives of chimeric antigen receptors against glioblastoma.
最后,我们讨论了串联 CAR 和 synNotch CAR 在靶向多种 GBM 抗原时的优势。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。